Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 04, 2022

SELL
$1.27 - $2.42 $55,876 - $106,472
-43,997 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$2.15 - $3.82 $4,749 - $8,438
2,209 Added 5.29%
43,997 $96,000
Q2 2021

Aug 02, 2021

SELL
$2.89 - $4.45 $1,994 - $3,070
-690 Reduced 1.62%
41,788 $157,000
Q1 2021

May 06, 2021

BUY
$2.9 - $4.09 $623 - $879
215 Added 0.51%
42,478 $138,000
Q4 2020

Jan 28, 2021

BUY
$3.38 - $5.14 $1,970 - $2,996
583 Added 1.4%
42,263 $144,000
Q3 2020

Nov 05, 2020

BUY
$2.99 - $4.9 $48,159 - $78,924
16,107 Added 62.98%
41,680 $170,000
Q2 2020

Aug 04, 2020

BUY
$2.11 - $3.38 $3,593 - $5,756
1,703 Added 7.13%
25,573 $86,000
Q1 2020

May 05, 2020

SELL
$1.83 - $3.45 $94,179 - $177,550
-51,464 Reduced 68.31%
23,870 $56,000
Q4 2019

Jan 27, 2020

SELL
$3.5 - $10.35 $200,242 - $592,144
-57,212 Reduced 43.16%
75,334 $274,000
Q3 2019

Oct 31, 2019

SELL
$7.03 - $9.7 $228,116 - $314,755
-32,449 Reduced 19.67%
132,546 $1.1 Million
Q2 2019

Jul 25, 2019

BUY
$7.36 - $11.26 $16,567 - $25,346
2,251 Added 1.38%
164,995 $1.42 Million
Q1 2019

Apr 29, 2019

BUY
$9.08 - $11.84 $57,485 - $74,959
6,331 Added 4.05%
162,744 $1.74 Million
Q4 2018

Jan 28, 2019

BUY
$6.39 - $16.99 $83,165 - $221,124
13,015 Added 9.08%
156,413 $1.37 Million
Q3 2018

Oct 29, 2018

BUY
$16.52 - $24.82 $117,539 - $176,594
7,115 Added 5.22%
143,398 $2.41 Million
Q2 2018

Aug 07, 2018

SELL
$14.31 - $21.75 $95,690 - $145,442
-6,687 Reduced 4.68%
136,283 $2.86 Million
Q1 2018

May 14, 2018

SELL
$16.09 - $23.07 $149,637 - $214,551
-9,300 Reduced 6.11%
142,970 $2.3 Million
Q4 2017

Feb 09, 2018

BUY
$13.36 - $20.73 $1.51 Million - $2.34 Million
112,815 Added 285.93%
152,270 $2.89 Million
Q3 2017

Nov 14, 2017

BUY
$8.75 - $14.07 $345,231 - $555,131
39,455
39,455 $555,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.